ADRD Specific Milestone
Expand efforts to genotype patients with FTD, identify new risk factor genes and epigenetic modifiers.
- Support efforts to genotype and perform genomic analyses on patients across the full spectrum of FTLD.
- Research Implementation Area
- Drug Development - Novel Targets
- In Progress
- RFA-NS-17-017: Frontotemporal Degeneration (FTD) Sequencing Consortium: Discovery, Replication and Validation (UG3/UH3)